Hepatitis C Leukopak

HEPATITIS C LEUKOPAK

Hepatitis C (HCV) primarily causes a long-lasting liver disease. It is spread by contact with infected blood. It first became evident in 1974 that a non A/non B hepatitis virus existed. Finally, a test was discovered that could be used to identify the virus in 1989 and from the early 1990s all blood units were screened for HCV. Hepatitis C is more likely than Hepatitis B to cause liver disease.

Leukopaks are obtained by a donation process where blood is withdrawn from the donor via leukapheresis utilizing an aphresis machine such as the Spectra Optia. The donor’s white blood cells are selectively collected and the remaining blood is reinfused to the body.

PPA's fresh Hepatitis C leukopaks are obtained by aphresis from donors with Hepatitis C. All of our donors are fully consented and IRB approved.

Contact Us: Mon-Fri EST 8:30am-PST 5:30pm
+1 423-389-9695 
   Contact Us
Catalog #NameUnitPriceAction
34-03002Fresh Hepatitis C Leukopak Half Pak $6,500.00Add to Cart
34-03001Fresh Hepatitis C Leukopak Quarter Pak $4,500.00Add to Cart

Disclaimer

Products sold or distributed by Physicians Plasma Alliance or PPA Research Group are intended and labeled for "Research Use Only" and are never to be used in humans, human trials or used in a manner inconsistent with "Research Use Only" labeling.

Customers' review

5 stars 0 0 %
4 stars 0 0 %
3 stars 0 0 %
2 stars 0 0 %
1 star 0 0 %

Reviews

There are no reviews yet.

Be the first to review “Hepatitis C Leukopak”

Product Categories:
Diseased Leukopaks, Human Disease Products
Product Format:
Fresh
Disclaimer:
PPA’s products are intended for research use only and not for direct therapeutic or diagnostic use in human or animals, or for further manufacturing of therapeutic products or devices.
No Protocols and COA available.